Trial
NCT00556205
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Massachusetts General Hospital
Collaborators
Beth Israel Deaconess Medical Center; Pfizer
Condition
Renal Cell Carcinoma
Intervention
Sunitinib
Why stopped
Toxicity of combination from other trials
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-24